The homozygous deletion of SMN1 exon 7 accounts for about 94% of SMA patients, while compound heterozygous, where a deletion on one allele and one subtle mutation on the other one is responsible for the rest cases [2]. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.